Dharmacon, Inc.

News Headlines

Two German-Based Sister Companies Plans to Develop Workflows for Use of 454 Sequencing Systems in Human Genetics
20 August 2010
IMGM Laboratories and the Center for Human Genetics and Laboratory Medicine will use the GS FLX System and GS Junior System for the joint development program.

Parent Project Muscular Dystrophy Awards $600K to Nationwide Children's Hospital for Gene Therapy Study
16 August 2010
Dr. Jerry Mendell to lead follistatin gene therapy for Duchenne muscular dystrophy.

Biosearch Technologies Expands Licensing of QIAGEN Scorpions®
13 August 2010
According to the agreement, the company obtains rights to manufacture primer assays for research, applied markets and infectious diseases.

Idaho Technology Issues License to DuPont Qualicon
03 August 2010
Agreement extends Idaho’s ongoing program to license its intellectual property portfolio in cooperation with Roche Diagnostics

Apticraft Systems Completes the Primer Premier Project
29 July 2010
Primer Premier 6.00 has been developed to enable users to design specific PCR and SNP genotyping assays.

Asuragen and Collaborators Report Results Using PCR-only Technologies
27 July 2010
Results demonstrate comprehensive molecular profiling of the Fragile X Mental Retardation gene using advanced PCR-based methods.

Clontech Laboratories and TET Systems Announce the Broadening of their License Agreement
27 July 2010
Clontech obtains rights to develop, manufacture and commercialize novel Tet Systems products as the Tet-On® 3G™ Inducible Expression System.

TriLink Enters Into Distribution and Supply Agreement with Affymetrix
21 July 2010
Under the terms of agreement, Affymetrix will use TriLink's high quality oligonucleotides in several of their kits.

  
Select Biosciences Ltd